Kerri-Ann Millar
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kerri-Ann Millar
Earlier roles on record: CFO at Cue Biopharma, Inc. (CUE) until June 13, 2025. Cue Biopharma, Inc. reported in an 8-K filed June 10, 2025 that Kerri-Ann Millar resigned as Chief Financial Officer, effective June 13, 2025. The proxy statement of Cue Biopharma, Inc. reports total compensation of $1,044,784 for Kerri-Ann Millar in fiscal 2024, including a base salary of $463,000. Disclosed compensation is on record for 6 fiscal years. Kerri-Ann Millar has spoken on 11 earnings calls across 1 company, most recently for Cue Biopharma, Inc. on December 31, 2023.
“On June 4, 2025, Kerri-Ann Millar notified the Company that she is resigning from her position as Chief Financial Officer, effective June 13, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cue Biopharma, Inc. (CUE)
Proxy statement
Start not stated–2020-05-29
Last confirmed by a filing; no departure on record
-
Start not stated–2025-06-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $463,000 | $1,044,784 |
| 2023 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $444,181 | $1,162,538 |
| 2022 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $418,459 | $1,056,925 |
| 2021 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $374,231 | $1,358,011 |
| 2020 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $292,500 | $2,194,633 |
| 2019 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $215,000 | $448,321 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.